Your browser doesn't support javascript.
loading
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Xiao, Zhiwen; Xu, Huaxiang; Strosberg, Jonathan R; Lu, Renquan; Zhu, Xinzhe; Deng, Shengming; Ding, Lei; Ni, Quanxing; Warshaw, Andrew L; Yu, Xianjun; Luo, Guopei.
  • Xiao Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu H; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Strosberg JR; Pancreatic Cancer Institute, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Lu R; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Deng S; Pancreatic Cancer Institute, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Ding L; Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Ni Q; Department of Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Warshaw AL; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Yu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Luo G; Pancreatic Cancer Institute, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai, China.
Int J Cancer ; 153(1): 164-172, 2023 07 01.
Article en En | MEDLINE | ID: mdl-36891979
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article